Pediatr. praxi. 2011;12(1):22-29

Chronic constipation in children

prof.MUDr.Jiří Nevoral, CSc.
Univerzita Karlova v Praze, 2. LF a FN v Motole, Pediatrická klinika

Constipation is one of the common complaints for which children present to paediatricians and paediatric gastroenterologists. In up to

95 % of the cases, the problem is functional constipation. Early defaecation difficulties, resulting in pain, fear and refusal to use the potty

or lavatory, may lead to creating a vicious cycle with stool retention in the rectum, which may then be accompanied by encopresis. The

management of chronic constipation requires a long-term approach with several phases: education and psychological guidance, removal

of the retained stool and maintenance therapy in order to prevent further retention. Therapeutic advances include the use of novel

osmotic agents such as polyethylene glycol (macrogol 4 000). In a meta-analysis of randomized comparative clinical trials, polyethylene

glycol was shown to be more effective than lactulose. Polyethylene glycol is not fermented by the bacterial microflora in the colon, the

production of gas is not increased and, thus, flatulence is less frequent compared to lactulose.

Keywords: chronic constipation, polyethylene glycol, macrogol

Published: February 23, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevoral J. Chronic constipation in children. Pediatr. praxi. 2011;12(1):22-29.
Download citation

References

  1. Hyman PE, Milla PJ, Benninga MA, et al. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 2006; 130(5): 1519-1526. Go to original source... Go to PubMed...
  2. Baullauf A. Habituelle Obstipation und Enkopresis. In Pädiatrische Gastroenterologie, Hepatologie und Ernährung, Rodeck, Zimmer eds. Springer Medizin Verlag 2008.
  3. Evaluation and treatment of constipation in infants and children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2006; 43: e1-e13. Go to PubMed...
  4. Obstipation im Kindesalter. Leitlinien der Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE), 2007.
  5. Candy D, Belsey J. Macrogol (polyethylene glycol) laxatives in children with functional constipation and faecal impaction: a systematic review. Arch Dis Child 2009; 94(2): 156-160. Go to original source... Go to PubMed...
  6. Candy D. Management of the child with difficult constipation. Paediatrics and Child Health 2009; 19: 11. Go to original source...
  7. Dupont Ch, Leluyer B, Amar F, et al. A dose determination study of polyethylene glycol 4000 in constipated children: Factors influencing the mainternance dose. J Pediatr Gastroenterol 2006; 42: 178-185. Go to original source... Go to PubMed...
  8. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst. Rev. 2010, 7 CD007570.
  9. Sharif F, Crushell E, O´Driscoll K, Bourke B. Liquid paraffin: a reappraisal of its role in the treatment of constipation. Arch Dis Child 2001; 85: 121-124. Go to original source... Go to PubMed...
  10. Urganci N, Akylidiz B, Polat TB. A comparative study: the efficacy of liquid paraffin and lactulose in management of chronic functional constipation. Pediatr Int 2005; 47: 15-19. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.